{ "schemaVersion": 1, "organisationId": "O-f71b720c6259412f8c012b36e216b617", "slug": "bio-rad-laboratories-inc", "name": "BIO-RAD LABORATORIES, INC.", "updatedAt": "2026-10-02T13:11:15.824979Z", "sections": [ { "type": "OVERVIEW", "text": "Bio-Rad Laboratories, Inc. is a multinational life-science and clinical-diagnostics company that develops, manufactures, and markets instruments, systems, reagents, and consumables. Its two principal businesses are Life Science, serving research, biopharmaceutical, food-safety, and education markets, and Clinical Diagnostics, which supplies diagnostic testing systems and related products to laboratories. [P26687533][P25263374][P60045741][P6900038]\n\nThe company operates worldwide, with direct operations in more than 36 countries outside the United States; in 2025, approximately 60% of sales were international. [P46348068][P25263374] Bio-Rad’s stated mission is “We advance science and save lives, together.” [https://careers.bio-rad.com/] For 2025, it reported revenue of $2.58 billion. [T11571385] The company reported about 7,400 employees as of December 2025 and says it serves customers in more than 100 regions. [https://www.bio-rad.com/en-us/about/about-us?ID=1756930869883]\n[P26687533][P25263374][P60045741][P6900038][P46348068][T11571385][https://careers.bio-rad.com/][https://www.bio-rad.com/en-us/about/about-us?ID=1756930869883]", "updatedAt": "2026-10-02T13:11:15.824979Z" }, { "type": "PRODUCTS", "text": "Bio-Rad’s Life Science products include instruments, systems, reagents and consumables used to separate, purify, characterize and quantify cells, proteins and nucleic acids, including for research and biopharmaceutical manufacturing and quality control. Its QX700 Droplet Digital PCR platform supports seven-channel multiplexing; E, S and HT configurations accommodate up to 48, 192 and 384 wells per run, respectively. Bio-Rad also offers chromatography systems and components, including medium- and low-pressure systems, fraction collectors, resins and columns for biomolecule purification. [P60045741][https://www.bio-rad.com/en-us/sku/17011036-qx700-e-droplet-digital-pcr-system?ID=17011036][https://www.bio-rad.com/en-us/sku/17010638-qx700-s-droplet-digital-pcr-system?ID=17010638][https://www.bio-rad.com/en-us/sku/17010628-qx700-ht-droplet-digital-pcr-system?ID=17010628][https://www.bio-rad.com/en-us/category/chromatography-systems-components?ID=00beeaa9-651e-44d2-ac80-efa0bcdee0fd]\n\nClinical Diagnostics offerings include diagnostic test systems, informatics, test kits and specialized quality controls for clinical laboratories. Examples include the IH-1000, a fully automated immunohematology system using gel cards with continuous sample and reagent loading; the BioPlex 2200, a random-access multiplex testing platform for autoimmune, infectious-disease and specialty testing; and the D-100, an HPLC-based hemoglobin testing system with stated throughput of 80 tests per hour. The company also provides instrument access through reagent-rental arrangements, in which customers pay per test; arrangements may include instrument maintenance and initial training. [P6900038][https://www.bio-rad.com/en-us/product/ih-1000-system?ID=M0FPV8IVK][https://www.bio-rad.com/en-us/product/bioplex-2200-system?ID=179032f7-5b80-4a4d-a5c9-9218a62c6eb3][https://www.bio-rad.com/en-us/product/d-100-hemoglobin-testing-system?ID=NVVIV7E8Z][P20997130]\n\nFor 2025, Life Science and Clinical Diagnostics accounted for approximately 40% and 60% of consolidated sales, respectively. [P25263374]\n[P60045741][P6900038][P20997130][P25263374][https://www.bio-rad.com/en-us/sku/17011036-qx700-e-droplet-digital-pcr-system?ID=17011036][https://www.bio-rad.com/en-us/sku/17010638-qx700-s-droplet-digital-pcr-system?ID=17010638][https://www.bio-rad.com/en-us/sku/17010628-qx700-ht-droplet-digital-pcr-system?ID=17010628][https://www.bio-rad.com/en-us/category/chromatography-systems-components?ID=00beeaa9-651e-44d2-ac80-efa0bcdee0fd][https://www.bio-rad.com/en-us/product/ih-1000-system?ID=M0FPV8IVK][https://www.bio-rad.com/en-us/product/bioplex-2200-system?ID=179032f7-5b80-4a4d-a5c9-9218a62c6eb3][https://www.bio-rad.com/en-us/product/d-100-hemoglobin-testing-system?ID=NVVIV7E8Z][https://www.bio-rad.com/en-us/sku/17011036-qx700-e-droplet-digital-pcr-system?ID=17011036][https://www.bio-rad.com/en-us/sku/17010638-qx700-s-droplet-digital-pcr-system?ID=17010638][https://www.bio-rad.com/en-us/sku/17010628-qx700-ht-droplet-digital-pcr-system?ID=17010628][https://www.bio-rad.com/en-us/category/chromatography-systems-components?ID=00beeaa9-651e-44d2-ac80-efa0bcdee0fd][https://www.bio-rad.com/en-us/product/ih-1000-system?ID=M0FPV8IVK][https://www.bio-rad.com/en-us/product/bioplex-2200-system?ID=179032f7-5b80-4a4d-a5c9-9218a62c6eb3][https://www.bio-rad.com/en-us/product/d-100-hemoglobin-testing-system?ID=NVVIV7E8Z]", "updatedAt": "2026-10-02T13:11:15.824979Z" }, { "type": "GEOGRAPHY", "text": "Bio-Rad reported that approximately 40% of its 2025 net sales were in the United States and 60% internationally, with Europe its largest international region. Its regional revenue mix was approximately 46% Americas, 34% EMEA and 20% Asia Pacific; these rounded figures are regional shares, with the Americas including the U.S. [P90836054][P34292823] The company reported more than 7,400 employees worldwide, but the available 2025 information does not specify their distribution by region. [P31776576]\n\nHeadquarters are in Hercules, California. Principal manufacturing and research locations span the U.S., England, Germany, China, Poland, Switzerland, France and Singapore, including facilities in Oxford, Shanghai, Suzhou, Warsaw, Cressier, Lille, Leipzig and Singapore, as well as several U.S. locations. Bio-Rad also leases offices and warehouses worldwide, primarily for sales, service, distribution and administration. [P90836054][T5369223]\n[P90836054][P34292823][P31776576][T5369223]", "updatedAt": "2026-10-02T13:11:15.824979Z" }, { "type": "SEGMENTS", "text": "Bio-Rad Laboratories reports two worldwide industry segments in its FY2025 reporting: **Life Science**, which develops and markets instruments, systems, reagents, and consumables used to separate, purify, characterize, and quantify biological materials. Its applications include research and biopharma labs and manufacturing, quality control, food safety, and science education. Life Science generated approximately 40% of 2025 net sales ($1,021.1 million). [P13778478][P60045741][P25263374][T5338579] **Clinical Diagnostics** provides diagnostic test systems, informatics solutions, test kits, and specialized quality controls for clinical laboratories, with a focus on differentiated in-vitro diagnostic applications. It generated approximately 60% of 2025 net sales ($1,562.1 million). [P6900038][P25263374][T5338579]\n\nThe company also discloses revenue by geography, with approximately 40% from the United States and 60% internationally; both industry segments operate worldwide. [P25263374][P97856657]\n[P13778478][P60045741][P25263374][T5338579][P6900038][T5338579][P97856657]", "updatedAt": "2026-10-02T13:11:15.824979Z" }, { "type": "HISTORY", "text": "Founded in Berkeley, California, in 1952 by David and Alice Schwartz, Bio-Rad initially made biochemical and radiochemical products. Its subsequent expansion included the Bio-Gel P chromatography product and, in 1967, a thyroid diagnostic test, as it grew from research supplies into clinical diagnostics and laboratory products. [https://www.bio-rad.com/en-us/about/our-history?ID=1757378124555] [https://www.bio-rad.com/webroot/web/pdf/corporate/literature/BR_historyV3.pdf]\n\nThe company broadened its capabilities through acquisitions, including Environmental Chemical Specialties in 1975, Pasteur Sanofi Diagnostics in 1999, and DiaMed in 2007. [https://www.bio-rad.com/webroot/web/pdf/corporate/literature/BR_historyV3.pdf] [https://www.bio-rad.com/webroot/web/pdf/corporate/literature/2008_annual.pdf] Norman Schwartz became president and CEO in 2003, succeeding his father David in those roles. [https://www.bio-rad.com/en-us/about/our-history?ID=1757378124555]\n\nLater acquisitions included AbD Serotec in 2013, single-cell analysis company Celsee in 2020, and Curiosity Diagnostics in 2022. [https://investors.bio-rad.com/press-releases/news-details/2013/Bio-Rad-Acquires-AbD-Serotec-a-Division-of-MorphoSys-AG/default.aspx] [https://investors.bio-rad.com/press-releases/news-details/2020/Bio-Rad-Acquires-Celsee-Inc--a-Single-Cell-Analysis-Solutions-Provider-04-08-2020/default.aspx] [https://investors.bio-rad.com/press-releases/news-details/2022/Bio-Rad-Acquires-Curiosity-Diagnostics/default.aspx] In 2025, Bio-Rad completed its acquisition of Stilla Technologies, adding digital PCR technology; co-founder Alice Schwartz died that year, aged 99. [https://www.bio-rad.com/en-us/bio-rads-acquisition-stilla-technologies/1751570278475] [https://investors.bio-rad.com/press-releases/news-details/2025/Bio-Rad-Laboratories-Inc--Co-Founder-and-Director-Emeritus-Alice-Schwartz-Passes-Away/default.aspx]\n[P146011195][P42120489][https://www.bio-rad.com/en-us/about/our-history?ID=1757378124555][https://www.bio-rad.com/webroot/web/pdf/corporate/literature/BR_historyV3.pdf][https://www.bio-rad.com/webroot/web/pdf/corporate/literature/2008_annual.pdf][https://investors.bio-rad.com/press-releases/news-details/2013/Bio-Rad-Acquires-AbD-Serotec-a-Division-of-MorphoSys-AG/default.aspx][https://investors.bio-rad.com/press-releases/news-details/2020/Bio-Rad-Acquires-Celsee-Inc--a-Single-Cell-Analysis-Solutions-Provider-04-08-2020/default.aspx][https://investors.bio-rad.com/press-releases/news-details/2022/Bio-Rad-Acquires-Curiosity-Diagnostics/default.aspx][https://www.bio-rad.com/en-us/bio-rads-acquisition-stilla-technologies/1751570278475][https://investors.bio-rad.com/press-releases/news-details/2025/Bio-Rad-Laboratories-Inc--Co-Founder-and-Director-Emeritus-Alice-Schwartz-Passes-Away/default.aspx]", "updatedAt": "2026-10-02T13:11:15.824979Z" } ], "sources": [ { "id": "P26687533", "href": "https://app.finbar.com/go?id=P26687533", "label": "BIO-RAD LABORATORIES, INC. — Full financial report (2025 Y)", "documentId": "D-761b4c97cab04170958f384929d161f2" }, { "id": "P25263374", "href": "https://app.finbar.com/go?id=P25263374", "label": "BIO-RAD LABORATORIES, INC. — Full financial report (2025 Y)", "documentId": "D-761b4c97cab04170958f384929d161f2" }, { "id": "P60045741", "href": "https://app.finbar.com/go?id=P60045741", "label": "BIO-RAD LABORATORIES, INC. — Full financial report (2025 Y)", "documentId": "D-761b4c97cab04170958f384929d161f2" }, { "id": "P6900038", "href": "https://app.finbar.com/go?id=P6900038", "label": "BIO-RAD LABORATORIES, INC. — Full financial report (2025 Y)", "documentId": "D-761b4c97cab04170958f384929d161f2" }, { "id": "P46348068", "href": "https://app.finbar.com/go?id=P46348068", "label": "BIO-RAD LABORATORIES, INC. — Full financial report (2025 Y)", "documentId": "D-761b4c97cab04170958f384929d161f2" }, { "id": "https://careers.bio-rad.com/", "href": "https://careers.bio-rad.com/", "label": "careers.bio-rad.com" }, { "id": "T11571385", "href": "https://app.finbar.com/go?id=T11571385", "label": "BIO-RAD LABORATORIES, INC. — Press release (2025 Y)", "documentId": "D-2312989c1bed4544be4ed27352c8530a" }, { "id": "https://www.bio-rad.com/en-us/about/about-us?ID=1756930869883", "href": "https://www.bio-rad.com/en-us/about/about-us?ID=1756930869883", "label": "www.bio-rad.com" }, { "id": "https://www.bio-rad.com/en-us/sku/17011036-qx700-e-droplet-digital-pcr-system?ID=17011036", "href": "https://www.bio-rad.com/en-us/sku/17011036-qx700-e-droplet-digital-pcr-system?ID=17011036", "label": "www.bio-rad.com" }, { "id": "https://www.bio-rad.com/en-us/sku/17010638-qx700-s-droplet-digital-pcr-system?ID=17010638", "href": "https://www.bio-rad.com/en-us/sku/17010638-qx700-s-droplet-digital-pcr-system?ID=17010638", "label": "www.bio-rad.com" }, { "id": "https://www.bio-rad.com/en-us/sku/17010628-qx700-ht-droplet-digital-pcr-system?ID=17010628", "href": "https://www.bio-rad.com/en-us/sku/17010628-qx700-ht-droplet-digital-pcr-system?ID=17010628", "label": "www.bio-rad.com" }, { "id": "https://www.bio-rad.com/en-us/category/chromatography-systems-components?ID=00beeaa9-651e-44d2-ac80-efa0bcdee0fd", "href": "https://www.bio-rad.com/en-us/category/chromatography-systems-components?ID=00beeaa9-651e-44d2-ac80-efa0bcdee0fd", "label": "www.bio-rad.com" }, { "id": "https://www.bio-rad.com/en-us/product/ih-1000-system?ID=M0FPV8IVK", "href": "https://www.bio-rad.com/en-us/product/ih-1000-system?ID=M0FPV8IVK", "label": "www.bio-rad.com" }, { "id": "https://www.bio-rad.com/en-us/product/bioplex-2200-system?ID=179032f7-5b80-4a4d-a5c9-9218a62c6eb3", "href": "https://www.bio-rad.com/en-us/product/bioplex-2200-system?ID=179032f7-5b80-4a4d-a5c9-9218a62c6eb3", "label": "www.bio-rad.com" }, { "id": "https://www.bio-rad.com/en-us/product/d-100-hemoglobin-testing-system?ID=NVVIV7E8Z", "href": "https://www.bio-rad.com/en-us/product/d-100-hemoglobin-testing-system?ID=NVVIV7E8Z", "label": "www.bio-rad.com" }, { "id": "P20997130", "href": "https://app.finbar.com/go?id=P20997130", "label": "BIO-RAD LABORATORIES, INC. — Full financial report (2025 Y)", "documentId": "D-761b4c97cab04170958f384929d161f2" }, { "id": "P90836054", "href": "https://app.finbar.com/go?id=P90836054", "label": "BIO-RAD LABORATORIES, INC. — Full financial report (2025 Y)", "documentId": "D-761b4c97cab04170958f384929d161f2" }, { "id": "P34292823", "href": "https://app.finbar.com/go?id=P34292823", "label": "BIO-RAD LABORATORIES, INC. — Full financial report (2025 Y)", "documentId": "D-761b4c97cab04170958f384929d161f2" }, { "id": "P31776576", "href": "https://app.finbar.com/go?id=P31776576", "label": "BIO-RAD LABORATORIES, INC. — Full financial report (2025 Y)", "documentId": "D-761b4c97cab04170958f384929d161f2" }, { "id": "T5369223", "href": "https://app.finbar.com/go?id=T5369223", "label": "BIO-RAD LABORATORIES, INC. — Full financial report (2025 Y)", "documentId": "D-761b4c97cab04170958f384929d161f2" }, { "id": "P13778478", "href": "https://app.finbar.com/go?id=P13778478", "label": "BIO-RAD LABORATORIES, INC. — Full financial report (2025 Y)", "documentId": "D-761b4c97cab04170958f384929d161f2" }, { "id": "T5338579", "href": "https://app.finbar.com/go?id=T5338579", "label": "BIO-RAD LABORATORIES, INC. — Full financial report (2025 Y)", "documentId": "D-761b4c97cab04170958f384929d161f2" }, { "id": "P97856657", "href": "https://app.finbar.com/go?id=P97856657", "label": "BIO-RAD LABORATORIES, INC. — Full financial report (2025 Y)", "documentId": "D-761b4c97cab04170958f384929d161f2" }, { "id": "https://www.bio-rad.com/en-us/about/our-history?ID=1757378124555", "href": "https://www.bio-rad.com/en-us/about/our-history?ID=1757378124555", "label": "www.bio-rad.com" }, { "id": "https://www.bio-rad.com/webroot/web/pdf/corporate/literature/BR_historyV3.pdf", "href": "https://www.bio-rad.com/webroot/web/pdf/corporate/literature/BR_historyV3.pdf", "label": "www.bio-rad.com" }, { "id": "https://www.bio-rad.com/webroot/web/pdf/corporate/literature/2008_annual.pdf", "href": "https://www.bio-rad.com/webroot/web/pdf/corporate/literature/2008_annual.pdf", "label": "www.bio-rad.com" }, { "id": "https://investors.bio-rad.com/press-releases/news-details/2013/Bio-Rad-Acquires-AbD-Serotec-a-Division-of-MorphoSys-AG/default.aspx", "href": "https://investors.bio-rad.com/press-releases/news-details/2013/Bio-Rad-Acquires-AbD-Serotec-a-Division-of-MorphoSys-AG/default.aspx", "label": "investors.bio-rad.com" }, { "id": "https://investors.bio-rad.com/press-releases/news-details/2020/Bio-Rad-Acquires-Celsee-Inc--a-Single-Cell-Analysis-Solutions-Provider-04-08-2020/default.aspx", "href": "https://investors.bio-rad.com/press-releases/news-details/2020/Bio-Rad-Acquires-Celsee-Inc--a-Single-Cell-Analysis-Solutions-Provider-04-08-2020/default.aspx", "label": "investors.bio-rad.com" }, { "id": "https://investors.bio-rad.com/press-releases/news-details/2022/Bio-Rad-Acquires-Curiosity-Diagnostics/default.aspx", "href": "https://investors.bio-rad.com/press-releases/news-details/2022/Bio-Rad-Acquires-Curiosity-Diagnostics/default.aspx", "label": "investors.bio-rad.com" }, { "id": "https://www.bio-rad.com/en-us/bio-rads-acquisition-stilla-technologies/1751570278475", "href": "https://www.bio-rad.com/en-us/bio-rads-acquisition-stilla-technologies/1751570278475", "label": "www.bio-rad.com" }, { "id": "https://investors.bio-rad.com/press-releases/news-details/2025/Bio-Rad-Laboratories-Inc--Co-Founder-and-Director-Emeritus-Alice-Schwartz-Passes-Away/default.aspx", "href": "https://investors.bio-rad.com/press-releases/news-details/2025/Bio-Rad-Laboratories-Inc--Co-Founder-and-Director-Emeritus-Alice-Schwartz-Passes-Away/default.aspx", "label": "investors.bio-rad.com" }, { "id": "P146011195", "href": "https://app.finbar.com/go?id=P146011195", "label": "BIO-RAD LABORATORIES, INC. — Full financial report (2026 Q 2)", "documentId": "D-69c16a829d6f414691ede8e43ae8847b" }, { "id": "P42120489", "href": "https://app.finbar.com/go?id=P42120489", "label": "BIO-RAD LABORATORIES, INC. — Full financial report (2025 Y)", "documentId": "D-761b4c97cab04170958f384929d161f2" } ] }